The Future of Cancer Care

In this episode we are joined by Kevin Conroy, Chairman and Chief Executive Officer at Exact Sciences, to discuss cancer innovation, including the role of early detection in the future of healthcare, what screening, prevention, and detection could look like in the future, why diagnostic tests are important in fighting healthcare disparities, and a lot more.

Cologuard is intended to screen adults 45 and older at average risk for colorectal cancer. Rx only.

Please see important risk information at Cologuard.com and http://www.exactsciencespo.com/.

This episode is sponsored by Exact Sciences.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Subscribe to Our Podcasts





Featured Whitepapers

Featured Webinars